Registry for patients with early digestive tract neoplasms treated by endoscopic submucosal dissection
Endoscopic Submucosal Dissection Patients Registry in "Agrippa Ionescu" Hospital, Bucharest, Romania
Carol Davila University of Medicine and Pharmacy · NCT06033976
This study collects information from patients with early digestive tract growths treated with a special endoscopic technique to help improve future treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Carol Davila University of Medicine and Pharmacy (other) |
| Locations | 1 site (Bucharest) |
| Trial ID | NCT06033976 on ClinicalTrials.gov |
What this trial studies
This registry collects data on patients with pre-neoplastic or early neoplastic lesions in the digestive tract who are treated using the endoscopic submucosal dissection (ESD) technique. Each case will be documented in an electronic record, ensuring patient consent and compliance with legal requirements. The goal is to gather comprehensive information to improve understanding and treatment outcomes for these conditions.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 with epithelial or non-epithelial lesions in the esophagus, stomach, duodenum, or colon.
Not a fit: Patients under 18 or those unable to provide informed consent will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance treatment strategies and outcomes for patients with early digestive tract neoplasms.
How similar studies have performed: While registries for similar conditions exist, this specific approach using ESD for early neoplasms is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * epithelial pre-neoplastic (eg. adenoma, dysplasia) lesion on the esophageal, gastric, duodenal or colorectal mucosa * non-epithelial (eg. neuroendocrine tumor) lesion on the esophageal, gastric, duodenal or colorectal mucosa * age \> 18 years old * informed consent Exclusion Criteria: * age \< 18 years old * no informed consent
Where this trial is running
Bucharest
- "Agrippa Ionescu" Hospital — Bucharest, Romania (RECRUITING)
Study contacts
- Principal investigator: Mihai L Ciocirlan, Associate Professor — Carol Davila University of Medicine and Pharmacy
- Study coordinator: Ciocirlan L Mihai, Associate Professor
- Email: mihai.ciocirlan@umfcd.ro
- Phone: 0040722322625
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Neoplasm, Stomach, Neoplasm, Colorectal, Neoplasm, Esophagus, Neoplasm, Duodenal